Device Trial Radar · NCT02310100
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
Last checked: Nov 20, 2026Latest source record: Oct 12, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
178
Actual
Start
Jan 21, 2015
Primary completion
Feb 2017
Study completion Sep 17, 2021
Sponsor
- Lead sponsor
- Abbott Medical DevicesPublic (ABT)
- Sponsor type
- Industry
- First posted
- Dec 5, 2014
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A prospective, multicenter, interventional study to collect confirmatory evidence on the safety and effectiveness of the TactiCath® percutaneous ablation catheter in the post approval setting for the treatment of symptomatic paroxysmal atrial fibrillation using contact force assisted irrigated radiofrequency ablation.
Conditions
- Paroxysmal Atrial Fibrillation
Interventions
TactiCath Quartz treatmentDevice
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants Free From Recurrent, Symptomatic Paroxysmal Atrial Fibrillation (PAF), Atrial Flutter (AFL), and Atrial Tachycardia (AT)Time frame: 12 Months post ablation
- Number of Participants Experiencing a Device or Procedure-related Serious Adverse EventTime frame: 7 days
Locations
20 sites in 1 country. Site status is shown where the registry gives one.
Glendale Memorial Hospital and Health Center
Glendale, California
Regional Cardiology Associates
Sacramento, California
Emory University Hospital
Atlanta, Georgia
17 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.